Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Oxytocin for Second Trimester D&E
NCT06141447Phase 2Recruiting
- Sponsor
- University of Colorado Denver
- Start
- May 2024
- Primary completion
- Nov 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hemorrhage comparing Oxytocin with Placebo (2 arms). Primary endpoints: Hemorrhage and Quantitative blood loss. Started May 2024; status: recruiting.
02
Drugs
oxytocin
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT06141447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06141447.